The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans

European Neuropsychopharmacology

Volumn 22, Issue 7, 2012, Pages 492-500

  Silber, B ^a   Croft, R ^b   Camfield, D A ^a   Downey, L A ^a   Papafotiou, K ^a   Stough, C ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

D amphetamine; D methamphetamine; Event related potentials; Information processing; Working memory

Indexed keywords

DEXAMPHETAMINE; DEXTROMETHAMPHETAMINE; METHAMPHETAMINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUDITORY ODDBALL TASK; DRUG EFFECT; ELECTROENCEPHALOGRAM; EVENT RELATED POTENTIAL; EXPERIMENTAL TEST; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; ADULT; ANALYSIS OF VARIANCE; BRAIN WAVES; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; YOUNG ADULT;

EID: 84861483936     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.11.009     Document Type: Article

References (58)

1. Angrist B., Corwin J., Bartlik B., Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol. Psychiatry 1987, 22(11):1357-1368.
2. Asghar S.J., Tanay V.A.M., Baker G.B., Greenshaw A., Silverstone P.H. Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Hum. Psychopharmacol. 2003, 18(4):291-299.
3. Bakshi V.P., Geyer M.A., Taaid N., Swerdlow N.R. A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behav. Pharmacol. 1995, 6(8):801-809.
4. Brauer L.H., Ambre J., De Wit H. Acute tolerance to subjective but not cardiovascular effects of 4-amphetamine in normal, healthy men. J. Clin. Psychopharmacol. 1996, 16(1):72-76.
5. Brumaghim J.T., Klorman R., Strauss J. Does methylphenidate affect information processing? Findings from two studies on performance and P3b latency. Psychophysiology 1987, 24(3):361-373.
6. Callaway E. The pharmacology of human information processing. Psychophysiology 1983, 20(4):359-370.
7. Callaway E. Human information-processing: some effects of methylphenidate, age, and scopolamine. Biol. Psychiatry 1984, 19(5):649-662.
8. Coons H.W., Peloquin L.J., Klorman R. Effect of methylphenidate on young adults' vigilance and event-related potentials. Electroencephalogr. Clin. Neurophysiol. 1981, 51(4):373-387.
9. Cooper N.J., Keage H., Hermens D., Williams L.M., Debrota D., Clark C.R., Gordon E. The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology. J. Integr. Neurosci. 2005, 4(1):123-144.
10. Croft R.J., Barry R.J. EOG-correction of blinks with saccade coefficients: a test and revision of the aligned-artefact average solution. Clin. Neurophysiol. 2000, 111:440-443.
11. Donchin E., Coles M.G.H. Is the P300 component a manifestation of context updating?. Behav. Brain Sci. 1988, 11:357-374.
12. Donchin E., Karis D., Bashore T.R., Coles M.G.H., Gratton G. Cognitive psychophysiology and human information processing. Psychophysiology: Systems, Processes, and Applications 1986, 244-267.
13. Drummer O.H., Gerostamoulos J., Batziris H., Chu M., Caplehorn J.R.M., Robertson M.D., Swann P. The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci. Int. 2003, 134(2-3):154-162.
14. Fillmore M.T., Kelly T.H., Martin C.A. Effects of d-amphetamine in human models of information processing and inhibitory control. Drug Alcohol. Depend. 2005, 77(2):151-159.
15. Fitzpatrick P., Klorman R., Brumaghim J.T., Keefover R.W. Effects of methylphenidate on stimulus evaluation and response processes: evidence from performance and event-related potentials. Psychophysiology 1988, 25(3):292-304.
16. Fleming K., Bigelow L.B., Weinberger D.R., Goldberg T.E. Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacol. Bull. 1995, 31(2):357-362.
17. Gabbay F.H., Duncan C.C., McDonald C.G. Brain potential indices of novelty processing are associated with preference for amphetamine. Exp. Clin. Psychopharmacol. 2010, 18(6):470-488.
18. Halliday R., Callaway E., Naylor H. Visual evoked potential changes induced by methylphenidate in hyperactive children: dose/response effects. Electroencephalogr. Clin. Neurophysiol. 1983, 55(3):258-267.
19. Halliday R., Naylor H., Callaway E., Yano L., Walton P. What's done can't always be undone: the effects of stimulant drugs and dopamine blockers on information processing. Electroencephalogr. Clin. Neurophysiol. Suppl. 1987, 40:532-537.
20. Halliday R., Naylor H., Brandeis D., Callaway E., Yano L., Herzig K. The effect of d-amphetamine, clonidine, and yohimbine on human information processing. Psychophysiology 1994, 31(4):331-337.
21. Hart C.L., Haney M., Nasser J., Foltin R.W. Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol. Biochem. Behav. 2005, 81(3):559-568.
22. Hillyard S.A., Hansen J.C. Attention: electrophysiological approaches. Psychophysiology: Systems, Processes, and Applications 1986, 227-243.
23. Hutchison K.E., Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology 1999, 143(4):394-400.
24. Johnson R. A triarchic model of P300 amplitude. Psychophysiology 1986, 23(4):367-384.
25. Johnson B.A., Ait-Daoud N., Wells L.T. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 2000, 22(5):504-512.
26. Jonkman L.M., Kemner C., Verbaten M.N., Van Engeland H., Kenemans J.L., Camfferman G., Buitelaar J.K., Koelega H.S. Perceptual and response interference in children with attention-deficit hyperactivity disorder, and the effects of methylphenidate. Psychophysiology 1999, 36(4):419-429.
27. Kennedy R.S., Odenheimer R.C., Baltzley D.R., Dunlap W.P., Wood C.D. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviat. Space Environ. Med. 1990, 61(7):615-621.
28. Kröner S., Schall U., Ward P.B., Sticht G., Banger M., Haffner H.T., Catts S.V. Effects of prepulses and d-amphetamine on performance and event-related potential measures on an auditory discrimination task. Psychopharmacology 1999, 145(2):123-132.
29. Kumari V., Corr P.J., Mulligan O.F., Cotter P.A., Checkley S.A., Gray J.A. Effects of acute administration of d-amphetamine and haloperidol on procedural learning in man. Psychopharmacology 1997, 129(3):271-276.
30. Kumari V., Mulligan O.F., Cotter P.A., Poon L., Toone B.K., Checkley S.A., Gray J.A. Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers. Behav. Pharmacol. 1998, 9(7):567-576.
31. Kupietz S.S., Bartlik B., Angrist B., Winsberg B.G. Psychostimulant plasma concentration and learning performance. J. Clin. Psychopharmacol. 1985, 5(5):293-295.
32. Laruelle M., Abi-Dargham A., Van Dyck C.H., Rosenblatt W., Zea-Ponce Y., Zoghbi S.S., Baldwin R.M., Charney D.S., Hoffer P.B., Kung H.F., Innis R.B. SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med. 1995, 36(7):1182-1190.
33. Logan B.K. Methamphetamine-effects on human performance and behavior. Forensic Sci. Rev. 2002, 14(1-2):133-151.
34. McKetin R., Solowij N. Event-related potential indices of auditory selective attention in dependent amphetamine users. Biol. Psychiatry 1999, 45(11):1488-1497.
35. McKetin R., Ward P.B., Catts S.V., Mattick R.P., Bell J.R. Changes in auditory selective attention and event-related potentials following oral administration of d-amphetamine in humans. Neuropsychopharmacology 1999, 21(3):380-390.
36. Näätänen R. Attention and brainfunction. Attention and Brainfunction 1992.
37. Naylor H., Halliday R., Callaway E. The effect of methylphenidate on information processing. Psychopharmacology 1985, 86(1-2):90-95.
38. Ozdag M.F., Yorbik O., Ulas U.H., Hamamcioglu K., Vural O. Effect of methylphenidate on auditory event related potential in boys with attention deficit hyperactivity disorder. Int. J. Pediatr. Otorhinolaryngol. 2004, 68(10):1267-1272.
39. Patel S.H., Azzam P.N. Characterization of N200 and P300: selected studies of the Event-Related Potential. Int. J. Med. Sci. 2005, 2(4):147-154.
40. Picton T.W. The P300 wave of the human event-related potential. J. Clin. Neurophysiol. 1992, 9(4):456-479.
41. Polich J., Kok A. Cognitive and biological determinants of P300: an integrative review. Biol. Psychol. 1995, 41(2):103-146.
42. Rapoport J.L., Buchsbaum M.S., Weingartner H. Dextroamphetamine: cognitive and behavioral effects in normal and hyperactive boys and normal adult males. Psychopharmacol. Bull. 1980, 16(1):21-23.
43. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol. Res. 2010, 62(3):187-206.
44. Robbins T.W. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp. Brain Res. 2000, 133(1):130-138.
45. Schiffer W.K., Volkow N.D., Fowler J.S., Alexoff D.L., Logan J., Dewey S.L. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse 2006, 59(4):243-251.
46. Servan-Schreiber D., Carter C.S., Bruno R.M., Cohen J.D. Dopamine and the mechanisms of cognition: part II. d-amphetamine effects in human subjects performing a selective attention task. Biol. Psychiatry 1998, 43(10):723-729.
47. Shappell S.A., Kearns G.L., Valentine J.L., Neri D.F., DeJohn C.A. Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man. J. Clin. Pharmacol. 1996, 36(11):1051-1063.
48. Silber B.Y., Papafotiou K., Croft R.J., Ogden E., Swann P., Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology 2005, 179(3):536-543.
49. Silber B.Y., Croft R.J., Papafotiou K., Stough C. The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 2006, 187(2):154-169.
50. Solanto M.V. Clinical psychopharmacology of AD/HD: implications for animal models. Neurosci. Biobehav. Rev. 2000, 24(1):27-30.
51. Solomon P.R., Crider A., Winkelman J.W. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol. Psychiatry 1981, 16(6):519-537.
52. Strauss J., Lewis J.L., Klorman R. Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test. Psychophysiology 1984, 21(6):609-621.
53. Swerdlow N.R., Stephany N., Wasserman L.C., Talledo J., Shoemaker J., Auerbach P.P. Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology 2003, 28(4):640-650.
54. Taylor M.J., Voros J.G., Logan W.J., Malone M.A. Changes in event-related potentials with stimulant medication in children with attention deficit hyperactivity disorder. Biol. Psychol. 1993, 36(3):139-156.
55. Verbaten M.N., Overtoom C.C.E., Koelega H.S., Swaab-Barneveld H., Van der Gaag R.J., Buitelaar J., Van Engeland H. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. J. Abnorm. Child Psychol. 1994, 22(5):561-578.
56. Ward A.S., Kelly T.H., Foltin R.W., Fischman M.W. Effects of d-amphetamine on task performance and social behavior of humans in a residential laboratory. Exp. Clin. Psychopharmacol. 1997, 5(2):130-136.
57. Weiner I., Lubow R.E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 1988, 30(4):871-878.
58. Winsberg B.G., Javitt D.C., Shanahan-Silipo G. Electrophysiological indices of information processing in methylphenidate responders. Biol. Psychiatry 1997, 42(6):434-445.